Patents by Inventor Min-Jung Kim
Min-Jung Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250026002Abstract: A muscular strength assisting apparatus includes a muscular strength assisting portion that assists a user's muscular strength and a first connecting link including one side connected to one side of the muscular strength assisting portion and an opposite side rotatable relative to a shoulder of the user about a first rotation axis. The muscular strength assisting portion includes an upper arm module that assists muscular strength of an upper arm of the user and a link assembly including one side connected to one side of the upper arm module to be rotatable about a second rotation axis non-parallel to the first rotation axis and an opposite side disposed adjacent to a portion of a body of the user to be supported on the user.Type: ApplicationFiled: June 5, 2024Publication date: January 23, 2025Applicants: Hyundai Motor Company, Kia CorporationInventors: Kyu Jung KIM, Sung Woo Park, Hyun Seop Lim, Ju Young Yoon, Beom Su Kim, Min Woong Jeung, Seong Taek Hwang, Hyeon Jeong An, Ho Jun Kim, Moon Ki Jung, Soo Kyung Kang, Dong Jin Hyun, Hyo Joong Kim
-
Publication number: 20250026835Abstract: The present disclosure relates to an isolated anti-FcRN antibody, which is an antibody binding to FcRN (stands for neonatal Fc receptor, also called FcRP, FcRB or Brambell receptor) that is a receptor with a high affinity for IgG or a fragment thereof, a method of preparing thereof, a composition for treating autoimmune disease, which comprises the antibody, and a method of treating and diagnosing autoimmunre diseases using the antibody. The FcRn-specific antibody according to the present disclosure binds to FcRn non-competitively with IgG to reduce serum pathogenic auto-antibody levels, and thus can be used for the treatment of autoimmune diseases.Type: ApplicationFiled: July 3, 2024Publication date: January 23, 2025Applicant: HANALL BIOPHARMA CO., LTD.Inventors: Sung Wuk KIM, Seung Kook PARK, Jae Kap JEONG, Hyea Kyung AHN, Min Sun KIM, Eun Sun KIM, Hae-Young YONG, Dongok SHIN, Yeon Jung SONG, Tae Hyoung YOO
-
Publication number: 20250022716Abstract: A method of fabricating a semiconductor device includes providing a substrate, forming a target film, a first mask film, a second mask film, and an upper mask pattern on the substrate, forming a first spacer pattern that includes a first line portion and a second line portion, and a folding portion that connects the first line portion and the second line portion, forming a slit mask pattern that partially covers the first spacer pattern, forming a first mask pattern by patterning the second mask film using the slit mask pattern and the first spacer pattern as an etching mask, forming a second spacer pattern, forming a second mask pattern by patterning the first mask film using the second spacer pattern as an etching mask, and forming a plurality of target patterns by patterning the target film using the second mask pattern as an etching mask.Type: ApplicationFiled: April 30, 2024Publication date: January 16, 2025Inventors: Eun Jung KIM, Sung Woo KIM, Hyun Seo SHIN, Min Jeong CHO, Min Su CHOI
-
Publication number: 20250004610Abstract: In some implementations, a system may receive a user identifier associated with a user account, and may identify account identifiers associated with the user account. The system may obtain account information associated with the account identifiers, and may determine priority levels for the account identifiers based on the account information. A primary account identifier may be associated with a highest priority level. The system may transmit a first set of user interface (UI) data indicating account UI elements, corresponding to the account identifiers, and an order of the account UI elements based on the priority levels. A primary account UI element, corresponding to the primary account identifier, may be arranged first in the order. The first set of UI data may indicate a first set of the account information to be visually presented on the account UI elements and associated with the account identifiers corresponding to the account UI elements.Type: ApplicationFiled: September 13, 2024Publication date: January 2, 2025Inventors: Erik Jay Salazar DE LEON, Thomas DOHAN, II, Xiang LAN, Min Jung KIM, Albert BERGER, John HEINER, Vivian WANG, Jennifer L. ELLISON
-
Publication number: 20250002532Abstract: Novel peptides and nucleotides encoding the peptides, and compositions containing the peptides and/or nucleotides are disclosed. Also disclosed are uses of the peptides, nucleotides, and compositions. N-terminus and/or a C-terminus of the peptides may be capped. The peptides, nucleotides, and compositions are suitable for treating pain or a transient receptor potential cation channel subfamily V member 1 (TRPV1)-mediated disease.Type: ApplicationFiled: October 27, 2023Publication date: January 2, 2025Applicant: Rudacure CorporationInventors: Yong Ho KIM, Seung Hoon KIM, Min Jung KIM, Juil PARK, Hawon JEON, Yewon JANG
-
Publication number: 20250006972Abstract: The present disclosure relates to a subminiature cell assembly apparatus and an electrode stack manufacturing method using the same, and more particularly a subminiature cell assembly apparatus including a jig unit configured to allow an electrode and a separator to be stacked on an upper surface thereof, the upper surface being flat, a laser radiation unit located above the jig unit, a support unit provided with a jig groove into which the jig unit is inserted, the support unit including a vacuum suction portion located at opposite sides of the jig groove, and a display unit configured to measure and display a relative height of the jig unit or the support unit, wherein the jig unit or the support unit is movable relative to the support unit or the jig unit in a vertical direction, and an electrode stack manufacturing method using the same.Type: ApplicationFiled: September 8, 2023Publication date: January 2, 2025Applicant: LG Energy Solution, Ltd.Inventors: Min Jung Kim, Tai Joon Seo, Ha Ye Lin Choi
-
Publication number: 20240428300Abstract: In some implementations, a system may identify one or more account identifiers associated with a user identifier. Each account identifier may be associated with one or more categories each representing a type of interaction of one or more interactions associated with the account identifier. A respective interaction amount may be associated with each interaction. The system may determine, for each category, a total category amount that is a sum of interaction amounts for interactions in a particular category occurring within a particular time frame. The system may transmit user interface (UI) data associated with a multi-tab UI element including a plurality of tabs corresponding to the plurality of categories. Each tab may be associated with benefits information related to a category corresponding to that tab. A first tab, corresponding to a category having a highest total category amount, may be presented in a particular position in the multi-tab UI element.Type: ApplicationFiled: September 10, 2024Publication date: December 26, 2024Inventors: Thomas DOHAN, II, Erik Jay Salazar DE LEON, Xiang LAN, Min Jung KIM, Brett William BISHOP, John HEINER
-
Publication number: 20240403386Abstract: A method for an anomaly detection is provided. The method may include acquiring a score predictor trained using normal time-series data, wherein the score predictor is a deep learning model configured to output a conditional score for previous time-series data and the conditional score represents a gradient of data density, extracting data for a specific time and data segments corresponding to a period before the specific time from target time-series data, and predicting a conditional score for the data segments through the trained score predictor and conducting an anomaly determination for the data for the specific time using the predicted conditional score.Type: ApplicationFiled: May 30, 2024Publication date: December 5, 2024Applicants: SAMSUNG SDS CO, LTD., UIF (University Industry Foundation), Yonsei UniversityInventors: Hak Soo LIM, Min-Jung KIM, Se Won PARK, No Seong PARK
-
Patent number: 12137710Abstract: The present invention, which is a food composition for alleviating diabetes that contains Schisandra chinensis fruit water and bean juice as active ingredients, has a high inhibitory activity against ?-glucosidase and prevents a rise of the blood sugar after meals, thereby alleviating diabetes. The food composition for alleviating diabetes can be prepared in different forms, such as soy milk, powdered soy milk, other forms of soy milk, or processed bean curd, and used in the preparation of health functional foods for blood sugar control or foods for diabetics according to the Special Purpose Foods of the general foods. In addition, the food composition for alleviating diabetes according to the present invention, when further containing a saccharified material of grain, maintains viscosity similar to that of regular soy milk by preventing agglomeration of the liquid soy milk and improves sensory properties, so it can be suitable for use in beverages such as soy milk or other forms of soy milk.Type: GrantFiled: November 13, 2019Date of Patent: November 12, 2024Assignee: KOREA FOOD RESEARCH INSTITUTEInventors: Dai Ja Jang, Hye Jeong Yang, Min Jung Kim, Yu Jin Kim
-
Patent number: 12134671Abstract: The present invention relates to an alkyl acrylate compound-vinyl cyanide compound-aromatic vinyl compound graft copolymer including a seed prepared by polymerizing one or more compounds selected from the group consisting of an alkyl acrylate compound, an aromatic vinyl compound, and a vinyl cyanide compound and a multifunctional crosslinking agent; a core formed to surround the seed and prepared by polymerizing an alkyl acrylate compound and a multifunctional crosslinking agent; and a graft shell formed to surround the core and prepared by polymerizing an aromatic vinyl compound and a vinyl cyanide compound, wherein the multifunctional crosslinking agent has a weight average molecular weight of 600 to 1,400 g/mol, a method of preparing the alkyl acrylate compound-vinyl cyanide compound-aromatic vinyl compound graft copolymer, and a thermoplastic resin composition including the alkyl acrylate compound-vinyl cyanide compound-aromatic vinyl compound graft copolymer.Type: GrantFiled: November 3, 2020Date of Patent: November 5, 2024Assignee: LG CHEM, LTD.Inventors: Seyong Kim, Yong Yeon Hwang, Bong Keun Ahn, Min Jung Kim, Jang Won Park, Ji Yoon Jeon, Eun Ji Lee
-
Patent number: 12129374Abstract: The present invention relates to an acrylic graft copolymer, a method of preparing the same, and a thermoplastic resin composition including the same. More specifically, the acrylic graft copolymer of the present invention includes a seed, a core, and a graft shell. In this case, the graft shell includes 0.05 to 2 parts by weight of a reactive ultraviolet stabilizer based on 100 parts by weight of the acrylic graft copolymer, and the graft shell has an average particle diameter of 80 to 140 nm (greater than the average particle diameter of the core). The acrylic graft copolymer of the present invention has excellent impact strength, tensile strength, weather resistance, and surface gloss. In addition, when the acrylic graft copolymer is used, mold deposits may be reduced.Type: GrantFiled: September 11, 2020Date of Patent: October 29, 2024Assignee: LG CHEM, LTD.Inventors: Bong Keun Ahn, Yong Yeon Hwang, Min Jung Kim, Jang Won Park, Jiyoon Jeon, Eunji Lee, Seyong Kim
-
Publication number: 20240352116Abstract: A new use of M-CSF or G-CSF for diagnosis or treatment of pulmonary fibrosis is disclosed. A marker for diagnosing the level of development or progression of pulmonary fibrosis contains M-CSF and/or G-CSF; and a composition for preventing or treating pulmonary fibrosis, contains an M-CSF inhibitor and a G-CSF inhibitor as active ingredients. The present inventors have ascertained that M-CSF and/or G-CSF is a marker for development or progression of pulmonary fibrosis, and have confirmed that a composition, which contains M-CSF and G-CSF and which binds to M-CSF and G-CSF so that the inherent mechanism thereof can be prevented, has an effect of significantly inhibiting myofibroblast hyperplasia or pulmonary fibrosis of the pulmonary cells, and thus the marker and the composition of the present disclosure are expected to be effectively usable for diagnosis, prevention or treatment of pulmonary fibrosis.Type: ApplicationFiled: July 3, 2024Publication date: October 24, 2024Applicant: FNCT BIOTECH, INC.Inventors: Su Jae LEE, Mi Young CHOI, Jae Kyung MYUNG, Min Jung KIM, Hae June LEE
-
Publication number: 20240309198Abstract: The present disclosure relates to a thermoplastic resin composition, a method of preparing the same, and a molded article manufactured using the same. The thermoplastic resin composition includes graft copolymer (A) including a polymer seed including 51 to 77 % by weight of an alkyl (meth)acrylate and 23 to 49% by weight of an aromatic vinyl compound, a rubber core surrounding the polymer seed and including 78 to 90% by weight of an alkyl acrylate and 10 to 22% by weight of an aromatic vinyl compound, and a graft shell surrounding the rubber core and including 65 to 80% by weight of an aromatic vinyl compound, 14 to 25% by weight of a vinyl cyanide compound, and 3 to 15% by weight of an alkyl acrylate; and a non-graft copolymer (B) including an alkyl (meth)acrylate, an alkyl-substituted styrene-based compound, and a vinyl cyanide compound.Type: ApplicationFiled: August 25, 2022Publication date: September 19, 2024Applicant: LG CHEM, LTD.Inventors: Jiyoon JEON, Bong Keun AHN, Min Jung KIM, Jangwon PARK, Eunji LEE, Seyong KIM
-
Patent number: 12095084Abstract: A lithium secondary battery is disclosed herein. In some embodiments, a lithium battery includes a positive electrode having a lithium-nickel-cobalt-manganese-based electrode active material wherein nickel has a content of 80 mol % or greater, relative to the other transition metals, a negative electrode including a silicon-based negative electrode active material, a separator, and a non-aqueous electrolyte solution including a non-aqueous organic solvent and a lithium salt, the lithium salt being contained in a concentration of 1.8 M to 5 M, and wherein the lithium salt includes LiPF6 and a lithium bis(fluorosulfonyl)imide.Type: GrantFiled: March 31, 2023Date of Patent: September 17, 2024Assignee: LG Energy Solution, Ltd.Inventors: Won Kyung Shin, Kyoung Ho Ahn, Chul Haeng Lee, Jeong Woo Oh, Min Jung Kim
-
Publication number: 20240298944Abstract: Provided are a system, apparatus, and method for determining stress. The apparatus according to the present invention includes a communication interface and a processor connected to the communication interface, wherein the processor collects biometric data and survey data of a user through the communication interface, generates a personalized stress classification model on the basis of the biometric data and the survey data, and determines whether the user is stressed using the personalized stress classification model.Type: ApplicationFiled: September 27, 2023Publication date: September 12, 2024Applicant: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTEInventors: Kyoung Hyun PARK, Hyun Suk KIM, Min Jung KIM, Dae Sub YOON
-
Publication number: 20240301192Abstract: A thermoplastic resin composition includes an alkyl acrylate-aromatic vinyl compound-vinyl cyanide compound graft copolymer (A) including a seed obtained by polymerizing 45 to 72% by weight of an alkyl acrylate and 28 to 55% by weight of an aromatic vinyl compound, a rubber core formed to surround the seed and obtained by polymerizing 78 to 91% by weight of an alkyl acrylate and 9 to 22% by weight of an aromatic vinyl compound, and a graft shell formed to surround the rubber core and obtained by polymerizing 65 to 82% by weight of an aromatic vinyl compound, 12 to 30% by weight of a vinyl cyanide compound, and 3 to 15% by weight of an alkyl acrylate; and a non-graft copolymer (B) including an alkyl (meth)acrylate, an aromatic vinyl compound, a vinyl cyanide compound, and an imide-based compound.Type: ApplicationFiled: May 31, 2023Publication date: September 12, 2024Inventors: Eunji LEE, Bong Keun AHN, Min Jung KIM, Jangwon PARK, Jiyoon JEON, Seyong KIM
-
Publication number: 20240286994Abstract: The present invention relates to a novel squaramide derivative and a use thereof and provides a novel derivative through the strategy of replacing a compound having a urea core with the bioisolate squaramide, whereby the derivative exhibits an anticancer activity through eIF2? phosphorylation efficacy, wherein squaramide has a characteristic structure retaining a double bond linked to the carbonyl groups and the squaramide structure can be prepared by mediating a precursor bearing an amine group to the squarate ring, which is a squaric ring, through a conjugate addition reaction.Type: ApplicationFiled: May 31, 2022Publication date: August 29, 2024Applicants: PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, KOSIN UNIVERSITY INDUSTRY-ACADEMY COOPERATIONInventors: Hwayoung YUN, Jee-Yeong JEONG, Jinsook KWAK, Min Jung KIM, Soyeong KIM
-
Publication number: 20240279455Abstract: A thermoplastic resin composition including an alkyl (meth)acrylate-aromatic vinyl compound-vinyl cyanide compound graft copolymer (A) including a polymer seed including 70 to 85% by weight of an alkyl (meth)acrylate and 15 to 30% by weight of an aromatic vinyl compound, a rubber core surrounding the polymer seed and including 78 to 90% by weight of an alkyl acrylate and 10 to 22% by weight of an aromatic vinyl compound, and a graft shell surrounding the rubber core and including 65 to 80% by weight of an aromatic vinyl compound, 14 to 25% by weight of a vinyl cyanide compound, and 3 to 15% by weight of an alkyl acrylate; and a non-graft copolymer (B) including an alkyl (meth)acrylate, an aromatic vinyl compound, a vinyl cyanide compound, and an imide-based compound. The present disclosure also relates to a preparation method and a molded article.Type: ApplicationFiled: August 1, 2022Publication date: August 22, 2024Applicant: LG CHEM, LTD.Inventors: Eunji LEE, Bong Keun AHN, Min Jung KIM, Jangwon PARK, Jiyoon JEON, Seyong KIM
-
Patent number: D1047165Type: GrantFiled: May 7, 2022Date of Patent: October 15, 2024Inventor: Min Jung Kim
-
Patent number: D1054433Type: GrantFiled: February 16, 2022Date of Patent: December 17, 2024Assignee: Capital One Services, LLCInventors: Erik Jay Salazar De Leon, Thomas Dohan, II, Xiang Lan, Min Jung Kim, Albert Berger, John Heiner, Vivian Wang, Jennifer L Ellison